• Spatial Metabolomics Uncovers Hippocampal Lipid Changes in P

  2026-07-22

  This study applies spatial metabolomics to map lipid alterations in the hippocampus of rats with postoperative cognitive dysfunction (POCD) after cardiopulmonary bypass. It reveals that dysregulated sphingolipid metabolism and synaptic changes underlie cognitive deficits, and demonstrates that correcting these lipid imbalances—using agents such as myriocin—can reduce POCD incidence.

• Cortistatin Counters Steroid-Induced Bone Cell Apoptosis via

  2026-07-22

  This study reveals that cortistatin (CST) protects against glucocorticoid-driven osteonecrosis of the femoral head by restoring the GHSR1a/Akt pathway, reducing apoptosis in osteoblasts and endothelial cells. These findings highlight mechanistic links between CST signaling, Akt activity, and bone health, presenting translational opportunities for targeted pathway inhibition in related research areas.

• Linarin from Herba Patriniae Induces NSCLC Cell Cycle Arrest

  2026-07-21

  This study demonstrates that Linarin, a key component of Herba Patriniae, suppresses proliferation of non-small-cell lung cancer (NSCLC) cells by inducing G0/G1 cell cycle arrest and cellular senescence through downregulation of Cyclin A2/B1 and CHEK1. These findings offer mechanistic insights into Linarin's anti-cancer activity and highlight its potential as a novel therapeutic strategy for NSCLC.

• Pharmacokinetics of Corydalis Alkaloids in MASH: Transporter

  2026-07-21

  This study characterizes how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. By dissecting the roles of CYP450 enzymes and transporters such as P-glycoprotein, the research provides actionable guidance for optimizing dosing and understanding drug-drug interactions in MASH therapy.

• Butylated Hydroxyanisole (BHA): Antioxidant Mechanisms & Res

  2026-07-20

  Butylated hydroxyanisole (BHA) is a synthetic antioxidant used in oxidative stress research for its robust free radical scavenging capacity. Its high solubility in DMSO and ethanol, but not water, underpins its utility in cell-based and biochemical assays. Accurate deployment of BHA depends on concentration, solvent choice, and storage, as verified by both product data and peer-reviewed studies.

• Pronase E Protease Mixture: Driving Precision in Protein Pre

  2026-07-20

  Pronase E’s unrivaled proteolytic breadth unlocks high-resolution protein digestion and peptide mapping for translational oncology. Discover actionable workflows, troubleshooting strategies, and expert protocol enhancements that set this protease mixture apart for molecular biology research.

• Super-Enhancer–FOXA1–SLC7A11 Axis Drives Disulfidptosis in P

  2026-07-19

  The referenced study uncovers how a super-enhancer, via FOXA1, regulates SLC7A11 expression to trigger disulfidptosis in prostate cancer, particularly under glucose deprivation. These findings illuminate a novel regulatory axis and offer potential new targets for therapeutic intervention in treatment-resistant prostate cancer.

• Deuterated Azole CYP51 Inhibitors: Innovations for Fungal Th

  2026-07-18

  This study reports the design and evaluation of deuterated diphenyl azole alcohol-based CYP51 inhibitors, integrating Oteseconazole-like features. The research demonstrates improved antifungal activity, pharmacokinetic properties, and drug-resistance profiles, supporting the development of next-generation antifungal agents.

• Dabigatran: Quantitative Precision in Coagulation Assays

  2026-07-17

  Explore Dabigatran's unique role as a direct thrombin inhibitor in advanced coagulation function testing. This article provides a quantitative, protocol-driven perspective on assay optimization and practical decision-making for research and translational settings.

• Targeting AR and ARv7 in TNBC: Mechanistic Insights with EPI

  2026-07-17

  This study establishes the prognostic significance of androgen receptor (AR) and its splice variant ARv7 in triple-negative breast cancer (TNBC) and demonstrates that inhibition of these targets, particularly with EPI-001, suppresses metastatic and EMT pathways in vitro. The findings provide mechanistic rationale for exploring AR N-terminal domain inhibitors in AR-driven TNBC models.

• AEBSF.HCl in Lysosomal Protease Modulation: Transforming Cel

  2026-07-16

  Explore how AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) uniquely empowers researchers to dissect lysosomal protease roles in necroptosis and amyloid-beta modulation. This article reveals assay-critical insights not covered elsewhere.

• Dasatinib Monohydrate: Optimizing CML Resistance Research Wo

  2026-07-16

  Dasatinib Monohydrate (BMS-354825) transforms chronic myeloid leukemia research by enabling precise, multitargeted kinase inhibition—even in imatinib-resistant models. This article delivers advanced, data-backed protocols, troubleshooting guidance, and actionable insights from the latest studies to help labs maximize reproducibility and translational impact.

• Biotin (Vitamin B7) in Protein Biotinylation & Metabolic Res

  2026-07-15

  Biotin (Vitamin B7) from APExBIO empowers researchers to achieve high-precision protein biotinylation and metabolic assays with unparalleled sensitivity. This guide details advanced experimental workflows, data-driven troubleshooting, and unique insights inspired by recent breakthroughs in molecular motor research.

• Erastin as a Precision Ferroptosis Inducer: Protocols & Pitf

  2026-07-15

  Erastin empowers researchers to dissect ferroptosis in RAS/BRAF-mutant tumor cells with benchmark selectivity and reproducibility. This guide details advanced use-cases, stepwise workflow enhancements, and troubleshooting strategies, integrating insights from the latest cancer biology research.

• Dabigatran Etexilate: Mechanistic and Strategic Insights for

  2026-07-14

  Explore the transformative role of Dabigatran etexilate as a direct thrombin inhibitor, with an in-depth look at its biological mechanism, translational research applications, clinical edge in stroke prevention, and strategic guidance for optimizing anticoagulant studies. This article uniquely bridges mechanistic understanding with actionable advice for the next generation of coagulation science, and contextualizes APExBIO’s high-purity offering within a rapidly evolving research landscape.

16287 records 1/1086 page Next 12345 下5页 Last page